| Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo YL Su, X Wang, M Mann, TP Adamus, D Wang, DF Moreira, Z Zhang, ... Blood 135 (3), 167-180, 2020 | 118 | 2020 |
| STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers D Moreira, T Adamus, X Zhao, YL Su, Z Zhang, SV White, P Swiderski, ... Clinical Cancer Research 24 (23), 5948-5962, 2018 | 84 | 2018 |
| Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates L Shen, J Frencher, D Huang, W Wang, E Yang, CY Chen, Z Zhang, ... Proceedings of the National Academy of Sciences 116 (13), 6371-6378, 2019 | 82 | 2019 |
| Adoptive transfer of phosphoantigen-specific γδ T cell subset attenuates mycobacterium tuberculosis infection in nonhuman primates A Qaqish, D Huang, CY Chen, Z Zhang, R Wang, S Li, E Yang, Y Lu, ... The Journal of Immunology 198 (12), 4753-4763, 2017 | 80 | 2017 |
| Pathogenic events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis L Shen, CY Chen, D Huang, R Wang, M Zhang, L Qian, Y Zhu, AZ Zhang, ... Journal of virology 91 (14), e02310-16, 2017 | 45 | 2017 |
| B cell lymphoma immunotherapy using TLR9-targeted oligonucleotide STAT3 inhibitors X Zhao, Z Zhang, D Moreira, YL Su, H Won, T Adamus, Z Dong, Y Liang, ... Molecular Therapy 26 (3), 695-707, 2018 | 32 | 2018 |
| Cell-based high-throughput screening assay identifies 2′, 2′-difluoro-2′-deoxycytidine gemcitabine as a potential antipoliovirus agent Z Zhang, E Yang, C Hu, H Cheng, CY Chen, D Huang, R Wang, Y Zhao, ... ACS infectious diseases 3 (1), 45-53, 2017 | 24 | 2017 |
| Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses E Yang, R Yang, M Guo, D Huang, W Wang, Z Zhang, C Chen, F Wang, ... Emerging microbes & infections 7 (1), 1-12, 2018 | 17 | 2018 |
| Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients G Li, F Yang, X He, Z Liu, J Pi, Y Zhu, X Ke, S Liu, M Ou, H Guo, Z Zhang, ... Microbes and infection 22 (3), 119-126, 2020 | 16 | 2020 |
| Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors G Garrido, B Schrand, A Levay, A Rabasa, A Ferrantella, DM Da Silva, ... Cancer immunology research 8 (7), 856-868, 2020 | 11 | 2020 |
| Pre-transplant cytoreductive therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood stem cell … Q Wang, X Zhao, Z Liu, X Zhao, G Zhang, J Yao, X Zheng, L Zhang, ... American Journal of Cancer Research 10 (4), 1218, 2020 | 9 | 2020 |
| Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 J Hall, Z Zhang, S Bhattacharya, D Wang, M Alcantara, Y Liang, ... Molecular Therapy-Nucleic Acids, 2024 | 7 | 2024 |
| Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy Z Zhang, X Zhao, D Wang, D Moreira, YL Su, M Alcantara, P Swiderski, ... Molecular Therapy 29 (3), 1214-1225, 2021 | 6 | 2021 |
| Targeted Delivery of CpG-Mir-146a Mimic Oligonucleotides As a Therapeutic Strategy to Reduce NF-Κb-Mediated Pathogenic Inflammation and Myeloid Leukemia Progression SU Yu-Lin, Z Zhang, M Mann, X Wang, B Zhang, L Li, P Swiderski, ... Blood 132, 3501, 2018 | 3 | 2018 |
| Bow-tie architectures in biological and artificial neural networks: implications for network evolution and assay design S Hilliard, K Mosoyan, S Branciamore, G Gogoshin, A Zhang, DL Simons, ... iScience, 2023 | 2 | 2023 |
| Targeted Delivery of miR-146a Mimic Oligonucleotides as a Potential Therapeutic Approach to Modulate NF-kB Signaling in Myeloid Leukemia and Myeloproliferative Diseases Y Su, Z Zhang, P Swiderski, D Zeng, G Marcucci, M Boldin, M Kortylewski Experimental Hematology 64, S42, 2018 | 2 | 2018 |
| Targeted in vivo delivery of NF-κB decoy oligodeoxynucleotide augments efficacy of radiation therapy against B-cell lymphomas Z Zhang, X Zhao, D Moreira, YL Su, P Swiderski, S Forman, L Kwak, ... Cancer Research 80 (16_Supplement), 5356-5356, 2020 | 1 | 2020 |
| Oligo-Protac Strategy for Cell-Selective and Targeted Degradation of Activated Stat3 J Hall, Z Zhang, S Bhattacharya, D Wang, Y Liang, P Swiderski, N Vaidehi, ... MOLECULAR THERAPY 30 (4), 105-105, 2022 | | 2022 |
| Targeted RNA therapeutics for treatment of cancer and immunomodulation Z Zhang, YL Su, C Yu, M Alcantara, D Rossi, M Kortylewski RNA Therapeutics, 37-55, 2022 | | 2022 |
| Myeloid cell-targeted miR-146a mimic alleviates NF-κB-driven cytokine storm without interfering with CD19-specific CAR T cell activity against B cell lymphoma M Kortylewski, YL Su, X Wang, M Mann, D Moreira, Z Zhang, C Ouyang, ... Journal for ImmunoTherapy of Cancer 7 (S1), Art. No. O61, 2019 | | 2019 |
